RVMD, RVMDW · CIK 0001628171 · operating
Revolution Medicines, Inc. (RVMDW) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. The stock currently trades at $1.75, down 14.43% today, with a 52-week range of $1.94–$2.19.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-5.95 | $-5.95 | -66.2% | |
| 2024 | $-3.58 | $-3.58 | +7.3% | |
| 2023 | $-3.86 | $-3.86 | -25.3% | |
| 2022 | $-3.08 | $-3.08 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-25 | 0001193125-26-071563 | SEC ↗ |
| 2024-12-31 | 2025-02-26 | 0000950170-25-027736 | SEC ↗ |
| 2023-12-31 | 2024-02-26 | 0000950170-24-020145 | SEC ↗ |
| 2022-12-31 | 2023-02-27 | 0000950170-23-004645 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0000950170-22-002297 | SEC ↗ |
| 2020-12-31 | 2021-03-02 | 0001564590-21-010276 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001564590-20-014169 | SEC ↗ |